CSIMarket Company Name, Ticker, Suppliers, else..
 
Interpace Biosciences Inc   (PDII)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 28
 Employees 102
 Revenues (TTM) (Millions $) 37
 Net Income (TTM) (Millions $) 24
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Business Description


Interpace Biosciences Inc is a biotechnology company that focuses on developing and commercializing molecular diagnostics tests and related products for diagnosing and treating various types of cancer. The company's tests are based on analyzing genetic and other molecular markers within a patient's tumor tissue or blood sample, providing physicians with information that can help guide personalized treatment decisions. Interpace Biosciences Inc aims to provide accurate and reliable diagnostic solutions that improve patient outcomes and contribute to the advancement of precision medicine.


   Company Address: Waterview Plaza Parsippany 7054 NJ
   Company Phone Number: 776-6419   Stock Exchange / Ticker: PDII


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BEAT   -6.42%    
DGX   -1.71%    
GH   -4.6%    
MYGN        3.53% 
PRPH   -33.33%    
VCYT        1.33% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.54
Working Capital Ratio 2.22
Leverage Ratio (MRQ) 0.49
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) 18.44

Per Share Current
Earnings (TTM) 0.89 $
Revenues (TTM) 1.32 $
Cash Flow (TTM) 0.08 $
Cash 0.1 $
Book Value 0.84 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 358,029
Net Income per Employee (TTM) 239,676
Receivable Turnover Ratio (TTM) 6.12
Inventory Turnover Ratio (TTM) 49.69
Asset Turnover Ratio (TTM) 1.28

Profitability Ratios Current
Gross Margin (MRQ) 61.91 %
Operating Margin (MRQ) 3.52 %
Net Margin (MRQ) 1.73 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 85.91 %
Return On Investment (TTM) 104.17 %
Return On Equity (TTM) 142.98 %
Dividend Yield -
Pay out Ratio (TTM) -



Interpace Biosciences Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.